Detalhe da pesquisa
1.
Emerging Variants of Castration-Resistant Prostate Cancer.
Curr Oncol Rep
; 19(5): 32, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28361223
2.
Α-arrestins - new players in Notch and GPCR signaling pathways in mammals.
J Cell Sci
; 127(Pt 7): 1359-67, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24687185
3.
Α-arrestin 1 (ARRDC1) and ß-arrestins cooperate to mediate Notch degradation in mammals.
J Cell Sci
; 126(Pt 19): 4457-68, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23886940
4.
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes.
Res Sq
; 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38405800
5.
The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer.
Cancer Res Commun
; 3(8): 1447-1459, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37546702
6.
Extracellular Matrix in Synthetic Hydrogel-Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors.
Adv Mater
; 34(2): e2100096, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34676924
7.
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets.
Science
; 376(6596): eabe1505, 2022 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35617398
8.
Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer.
Nat Commun
; 12(1): 6377, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34737261
9.
SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy.
Mol Cancer Ther
; 19(5): 1157-1164, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32127465
10.
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity.
Nat Commun
; 11(1): 5549, 2020 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33144576
11.
Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies.
Cold Spring Harb Perspect Med
; 9(2)2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29844220
12.
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer.
Sci Transl Med
; 11(484)2019 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30894499
13.
N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.
J Clin Invest
; 129(9): 3924-3940, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31260412
14.
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.
Clin Cancer Res
; 25(1): 43-51, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30232224
15.
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.
JCO Precis Oncol
; 32019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31592503
16.
ONECUT2 is a driver of neuroendocrine prostate cancer.
Nat Commun
; 10(1): 278, 2019 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30655535
17.
Patient derived organoids to model rare prostate cancer phenotypes.
Nat Commun
; 9(1): 2404, 2018 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29921838
18.
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.
Cancer Discov
; 7(5): 462-477, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28331002
19.
An emerging role for cytopathology in precision oncology.
Cancer Cytopathol
; 124(3): 167-73, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26641771
20.
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.
Nat Med
; 22(3): 298-305, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26855148